Valeo Pharma Inc.

VPHIF · OTC
Analyze with AI
7/31/2024
4/30/2024
1/31/2024
10/31/2023
Operating Activities
Net Income-$8-$8-$7-$9
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$4$3
Stock-Based Comp.$0$0$0$0
Change in WC$4$2$6$4
Other Non-Cash$4$2-$3-$1
Operating Cash Flow$0-$4$1-$3
Investing Activities
PP&E Inv.$0-$0-$0-$5
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$1$0$0
Investing Cash Flow$0$1$0-$5
Financing Activities
Debt Repay.-$0-$1-$0$1
Stock Issued$0$0$0$4
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$1-$0
Financing Cash Flow-$0-$1$0$5
Forex Effect$0$0-$0$0
Net Chg. in Cash$0-$3$2-$2
Supplemental Information
Beg. Cash$7$10$8$10
End Cash$7$7$10$8
Free Cash Flow$0-$4$1-$8
Valeo Pharma Inc. (VPHIF) Financial Statements & Key Stats | AlphaPilot